Introduction The dumping syndrome is frequent in bariatric surgery. It is probably the most common syndrome following partial or complete gastrectomy. Its prevalence in partial gastrectomy can reach up to 50%, thus it can be a significant complication arising from some types of bariatric surgeries. Objective: Critical analysis on dumping syndrome, its pathophysiology, diagnosis and treatment. Methods: A literature review was performed using the key words: 'dumping syndrome', 'bariatric surgery' and 'rapid dumping syndrome'. Inclusion criteria were: books, original works, case reports and meta-analyzes, and the exclusion criterion was literature review. Concerning the publication time, articles were screened between 1960 and May 2015. Results: The dumping syndrome is complication arising from obesity surgeries, but also can be a result of vagus nerve damage. Diagnosis is done primarily through the use of questionnaires based on scores. Conclusion: The Sigstad score and Arts survey are valid means for assessing the dumping syndrome. Initial therapy consists in the adoption of dietary measures, short acting drugs administration.
The review article provides a comprehensive overview of the latest advancements in neuroradiological techniques and their clinical applications. It explores various advanced magnetic resonance imaging (MRI) methods, including diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI), perfusion-weighted imaging (PWI), functional MRI (fMRI), and magnetic resonance spectroscopy (MRS), as well as developments in computed tomography (CT) technology, such as multidetector CT (MDCT) and dual-energy CT (DECT). The article discusses the principles, applications, and limitations of these techniques, highlighting their impact on patient care, particularly in diagnosing and managing neurological conditions, including cerebrovascular diseases, brain tumors, neurodegenerative disorders, and traumatic brain injuries. The review also addresses the challenges and potential future directions in neuroradiology.
Introduction: In the blood transfusion patients may be exposed or are stimulated to produce red cell antibodies that cause immediate and delayed transfusion reactions. Antibodies that agglutinate the red blood cells are called signifiers. Already insignificant antibodies that agglutinate red blood cells "in vitro", and which do not promote changes in the body can be sub-categorized into Rh and Kell system, MNSs, Lewis, Duffy and Kidd. Objectives: Identify the types of irregular antibodies. Materials and Methods: This study was conducted through a wide reading-based research papers published from 2000 to 2014 available on the websites: Scielo - Scientific Electronic Library Online, LILLACS - Latin American and Caribbean Sciences WWII Health and PubMed - US National Library of Medicine and BIREME - Regional Library of Medicine. Inclusion criteria were: articles published in Portuguese, English and Spanish and exclusion criteria: review articles that do not directly addressed the issue of irregular antibodies and blood transfusion. Results and Discussion: We identified 51 articles on alternate sites: 43 in Scielo, 02 in BIREME, 01 in LILLACS and 05 found in PubMed. Only 22 articles met the inclusion criteria proposed for the study and were distributed in several categories: descriptive, quantitative and qualitative research. Conclusion: Common antibodies are Rh and Kell system. Erythrocyte sensitizations occur to each unit of transfused red blood cells. Therefore, phenotyping and genotyping for Rh, Kell, Duffy, Kidd and MNSs antibodies to patients undergoing blood transfusion is recommended for safe and quality therapy.
4 April 2024 in Revista CPAQV - Centro de Pesquisas Avançadas em Qualidade de Vida
Osteogenesis imperfecta (OI) is a complex genetic disorder characterized by fragile bones and frequent fractures. It is primarily caused by mutations affecting collagen type I production. Recent advancements in genetic research have identified multiple genes involved in the disorder, broadening the scope of potential targeted therapies. This narrative review synthesizes the latest developments in the management and treatment of OI, focusing on personalized therapeutic interventions.OI is classified into several types based on genetic mutations, each with distinct clinical manifestations. Most cases are linked to mutations in the COL1A1 and COL1A2 genes, which directly affect collagen quality and the bone matrix structure. Emerging therapies explored in this review include bisphosphonates, genetic engineering techniques such as CRISPR/Cas9, and novel pharmacological agents targeting specific molecular pathways involved in bone metabolism and repair. Recent studies have shown promising results in using gene therapy to correct defective genes and employing targeted drug therapies to modulate bone formation and resorption processes. These advancements underscore the potential of personalized medicine in providing more effective management strategies for patients with OI.The genetic heterogeneity of OI necessitates a multifaceted approach to treatment that encompasses both the correction of genetic defects and the modulation of bone metabolism pathways. Innovations in genetic engineering and drug therapy are paving the way for more tailored and effective treatments, which promise to significantly improve the quality of life for individuals with OI. Ongoing research and clinical trials are crucial for furthering our understanding of the disease mechanisms and developing safer, more effective therapeutic options.
3 April 2017 in Juniper Online Journal of Case Studies
Journal of Case reports is an international, peer reviewed open access journal, focussed on bringing out premium quality case reports in all areas of basic